NO922524L - Pyrimidinderivater, deres fremstilling og anvendelse - Google Patents

Pyrimidinderivater, deres fremstilling og anvendelse

Info

Publication number
NO922524L
NO922524L NO92922524A NO922524A NO922524L NO 922524 L NO922524 L NO 922524L NO 92922524 A NO92922524 A NO 92922524A NO 922524 A NO922524 A NO 922524A NO 922524 L NO922524 L NO 922524L
Authority
NO
Norway
Prior art keywords
preparation
pyrimidine derivatives
hydrogen atom
hydrogen
therapeutics
Prior art date
Application number
NO92922524A
Other languages
English (en)
Norwegian (no)
Other versions
NO922524D0 (no
Inventor
Pascal George
Jacques Froissant
Arlette Tixidre
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of NO922524D0 publication Critical patent/NO922524D0/no
Publication of NO922524L publication Critical patent/NO922524L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO92922524A 1991-06-27 1992-06-26 Pyrimidinderivater, deres fremstilling og anvendelse NO922524L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9107937A FR2678271B1 (fr) 1991-06-27 1991-06-27 Derives de pyrimidine-4-carboxamide, leur preparation et leur application en therapeutique.

Publications (2)

Publication Number Publication Date
NO922524D0 NO922524D0 (no) 1992-06-26
NO922524L true NO922524L (no) 1992-12-28

Family

ID=9414357

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92922524A NO922524L (no) 1991-06-27 1992-06-26 Pyrimidinderivater, deres fremstilling og anvendelse

Country Status (21)

Country Link
US (1) US5244901A (da)
EP (1) EP0522915B1 (da)
JP (1) JP3160371B2 (da)
KR (1) KR930000509A (da)
CN (1) CN1067884A (da)
AT (1) ATE135348T1 (da)
AU (1) AU645698B2 (da)
CA (1) CA2072528A1 (da)
CZ (1) CZ9202002A3 (da)
DE (1) DE69208955T2 (da)
DK (1) DK0522915T3 (da)
ES (1) ES2087477T3 (da)
FI (1) FI922983A (da)
FR (1) FR2678271B1 (da)
GR (1) GR3020055T3 (da)
HU (1) HUT61996A (da)
IE (1) IE922093A1 (da)
MX (1) MX9203331A (da)
NO (1) NO922524L (da)
PL (1) PL295021A1 (da)
ZA (1) ZA924787B (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2678272B1 (fr) * 1991-06-27 1994-01-14 Synthelabo Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique.
EP0577470B1 (fr) * 1992-07-03 1995-05-24 Synthelabo Dérivés de 2-amino-N-[[[4-(aminocarbonyl)pyrimidin-2-yl]-amino]alkyl]pyrimidine-4-carboxamide, leur préparation et leur application en thérapeutique
US5447916A (en) * 1993-07-30 1995-09-05 Chiron Corporation Peptoid alpha-1 adrenergic receptor ligands
US5889010A (en) * 1995-05-18 1999-03-30 Pfizer Inc. Benzimidazole derivatives having dopaminergic activity
PL199355B1 (pl) 1997-11-07 2008-09-30 Upjohn Co Drugorzędowy (S)-alkohol i sposób jego wytwarzania oraz sposób wytwarzania (S)-3-karboaminoalkoholu
TW536538B (en) 1998-02-20 2003-06-11 Ortho Mcneil Pharm Inc Phthalimido arylpiperazines useful in the treatment of benign prostatic hyperplasia
ZA991319B (en) 1998-02-20 2000-11-20 Ortho Mcneil Pharm Inc Novel phthalimido arylpiperazines useful in the treatment of benign prostatic hyperplasia.
EP1346983A3 (en) * 1998-02-20 2003-12-03 Ortho-Mcneil Pharmaceutical, Inc. Phthalimido arylpiperazines as alpha 1A receptor antagonists useful in the treatment of benign prostatic hyperplasia
EP1075486A1 (en) * 1998-05-06 2001-02-14 Duke University Method of treating bladder and lower urinary tract syndromes
JP3519302B2 (ja) 1999-02-09 2004-04-12 株式会社東海理化電機製作所 ウエビング巻取装置用プリテンショナー
KR100566188B1 (ko) * 1999-11-27 2006-03-29 동화약품공업주식회사 신규의 5-피리미딘카르복스아미드 유도체 및 그를포함하는 약학적 조성물
KR100566189B1 (ko) * 1999-12-29 2006-03-29 동화약품공업주식회사 신규의 5-피리미딘카르복스아미드 유도체 및 그를포함하는 약학적 조성물
WO2004018323A1 (en) 2002-08-23 2004-03-04 Pfizer Products Inc. Apparatus for dispensing articles
US20060276465A1 (en) * 2003-12-26 2006-12-07 Eisai R&D Management Co., Ltd. 1,2-di(cyclic) substituted benzene compounds
MY140489A (en) * 2003-12-26 2009-12-31 Eisai R&D Man Co Ltd 1,2-di (cyclic) substituted benzene compounds
US20090312344A1 (en) * 2004-05-31 2009-12-17 Mohammad Salman Arylpiperazine derivatives as adrenergic receptor antagonists
SE0402200D0 (sv) * 2004-09-13 2004-09-13 Astrazeneca Ab New process II
AU2005320217B2 (en) 2004-12-20 2011-11-10 Eisai R & D Management Co., Ltd. Crystal and salt of 1-cyclopropylmethyl-4-[2-(3,3,5,5)-tetramethylcyclohexyl)phenyl]piperazine
US7410971B2 (en) * 2004-12-24 2008-08-12 Eisai R&D Management Co., Ltd. 1,2-di(cyclic)substituted benzene compounds
ATE478854T1 (de) * 2005-05-25 2010-09-15 Eisai R&D Man Co Ltd Verfahren zur herstellung von ä2-(3,3,5,5- tetramethylcyclohexyl)phenylüpiperazin
MY144974A (en) * 2005-06-14 2011-11-30 Eisai R&D Man Co Ltd 1,2-di(cyclic) substituted benzene derivatives

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2143730A (en) * 1932-05-27 1939-01-10 Apex Electrical Mfg Co Clothes washer
DE2143730A1 (de) * 1971-09-01 1973-03-08 Byk Gulden Lomberg Chem Fab Substituierte pyridine, verfahren zu deren herstellung und sie enthaltende arzneimittel
FR2618436B1 (fr) * 1987-07-23 1989-10-27 Synthelabo Derives de piperidine, leur preparation et leur application en therapeutique
FR2620121B1 (fr) * 1987-09-09 1990-01-05 Synthelabo ((pyrimidinyl-2)-aminoalkyl)-1 piperidines, leur preparation et leur application en therapeutique
FR2656609B1 (fr) * 1989-12-28 1992-03-27 Synthelabo Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique.

Also Published As

Publication number Publication date
ATE135348T1 (de) 1996-03-15
FI922983A0 (fi) 1992-06-26
FR2678271A1 (fr) 1992-12-31
JPH05186434A (ja) 1993-07-27
AU645698B2 (en) 1994-01-20
AU1859092A (en) 1993-01-07
HUT61996A (en) 1993-03-29
NO922524D0 (no) 1992-06-26
FI922983A (fi) 1992-12-28
GR3020055T3 (en) 1996-08-31
CN1067884A (zh) 1993-01-13
IE922093A1 (en) 1992-12-30
KR930000509A (ko) 1993-01-15
CZ9202002A3 (en) 1993-01-13
ES2087477T3 (es) 1996-07-16
HU9202137D0 (en) 1992-10-28
EP0522915B1 (fr) 1996-03-13
ZA924787B (en) 1993-03-31
US5244901A (en) 1993-09-14
DE69208955D1 (de) 1996-04-18
DE69208955T2 (de) 1996-10-24
DK0522915T3 (da) 1996-07-22
PL295021A1 (en) 1993-03-08
EP0522915A1 (fr) 1993-01-13
JP3160371B2 (ja) 2001-04-25
MX9203331A (es) 1992-12-01
FR2678271B1 (fr) 1995-01-13
CA2072528A1 (en) 1992-12-28

Similar Documents

Publication Publication Date Title
NO922524D0 (no) Pyrimidinderivater, deres fremstilling og anvendelse
ES2084015T3 (es) Derivados de 2-aminopirimidina-4-carboxamida, su preparacion y su aplicacion en terapeutica.
ZA893651B (en) 6-phenyl-3-(piperazinylalkyl)-2,4(1h,3h)-pyrimidinedione derivatives,their preparation and their application in therapy
NO940788L (no) Benzoxazin-derivater, deres fremstilling og deres terapeutiske anvendelse
DK0515540T3 (da) Derivat af beta-phenylisoserin, dets fremstilling og anvendelse
DK0520882T3 (da) Derivater af 2-aminopyrimidin-4-carboxamid, deres fremstilling og deres terapeutiske anvendelse
NO932418L (no) Pyrimidinderivater, fremgangsmaate for deres fremstilling og terapeutiske anvendelse derav
ATE111099T1 (de) Ergolinderivate.